Enhua Pharmaceutical (002262): Steady growth in performance, focusing on the release of major new products
Enhua Pharmaceutical (002262): Steady growth in performance, continued release of new narcotics products
Enhua Pharmaceutical (002262): Rapid growth in anesthesia, optimistic about the continued release of new products
Enhua Pharmaceutical (002262): Steady performance, optimistic that anesthetic products will continue to grow
Enhua Pharmaceutical (002262): High growth in narcotic products, launch of major new products
Enhua Pharmaceutical (002262): Performance is in line with expectations, optimistic about core varieties to drive continued high performance growth
Enhua Pharmaceutical (002262): Steady Growth in Performance, Outstanding Performance of Anesthetic Products - Company Information Update Report
Enhua Pharmaceutical (002262): Performance is in line with expectations, and narcotic products are growing steadily
Enhua Pharmaceutical (002262): Rapid growth in performance, equity incentives show confidence in development
Enhua Pharmaceutical (002262): Steady growth in 2Q24
Enhua Pharmaceutical (002262) Company Information Update Report: The Company Releases an Equity Incentive Plan to Highlight Confidence in Long-term Performance
Enhua Pharmaceutical (002262): Equity incentive plan introduced to boost confidence in long-term stable development
Enhua Pharmaceutical (002262): Cannabis leading innovation drives growth
Enhua Pharmaceutical (002262): Expectations of not collecting midazolam to increase
Enhua Pharmaceutical (002262): 1Q24 performance is in line with expectations, focus on the pace of new product release
Enhua Pharmaceutical (002262): Performance is in line with expectations, optimistic about the release of new products to drive long-term growth
Enhua Pharmaceutical (002262): Steady growth in performance, new products entering the release cycle
Enhua Pharmaceutical (002262): Excellent performance in the first year of 1Q24
Enhua Pharmaceutical (002262): The world has gone through a thousand sails, breaking the waves
Enhua Pharmaceutical (002262): Optimistic about new products to drive rapid growth in refined hemp